Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Richard Day

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Anatomy

Synovial Fluid

Physiology

Drug Interactions

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Williams, Kenneth
12
Graham, Garry
10
McLachlan, Andrew
9
Cutler, David
4
Williams, Kenneth
3
Brooks, Peter
3
Westbrook, Johanna
3
Conaghan, Philip
2
Scott, Kieran
2
Woodworth, Thasia
2
Coiera, Enrico
2
Brown, KF
2
Tugwell, Peter
2
Johnson, Kent
2
Kirwan, John

Sign-in to see all Coauthors

Publications

TOP 3
Reckmann Margaret H; Westbrook Johanna I; Koh Yvonne; Lo Connie; Day Richard O
Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review.
Mohammed Abdul M I; Jiang X; Williams K M; Day R O; Roufogalis B D; Liauw W S; Xu H; McLachlan A J
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.
Chung Y; Lu C Y; Graham G G; Mant A; Day R O
Utilization of allopurinol in the Australian community.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Day (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Reckmann Margaret H; Westbrook Johanna I; Koh Yvonne; Lo Connie; Day Richard O
Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review.
Journal of the American Medical Informatics Association : JAMIA 2009;16(5):613-23.
2008: Mohammed Abdul M I; Jiang X; Williams K M; Day R O; Roufogalis B D; Liauw W S; Xu H; McLachlan A J
Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.
British journal of pharmacology 2008;154(8):1691-700.
2008: Chung Y; Lu C Y; Graham G G; Mant A; Day R O
Utilization of allopurinol in the Australian community.
Internal medicine journal 2008;38(6):388-95.
2008: Xu H; Williams K M; Liauw W S; Murray M; Day R O; McLachlan A J
Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.
British journal of pharmacology 2008;153(7):1579-86.
2008: Chung Yewon; Stocker Sophie L; Graham Garry G; Day Richard O
Optimizing therapy with allopurinol: factors limiting hypouricemic efficacy.
The American journal of the medical sciences 2008;335(3):219-26.
2008: Lee Ming-Han H; Graham Garry G; Williams Kenneth M; Day Richard O
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?
Drug safety : an international journal of medical toxicology and drug experience 2008;31(8):643-65.
2008: Magrabi Farah; Westbrook Johanna I; Kidd Michael R; Day Richard O; Coiera Enrico
Long-term patterns of online evidence retrieval use in general practice: a 12-month study.
Journal of medical Internet research 2008;10(1):e6.
2008: Stocker Sophie L; Williams Kenneth M; McLachlan Andrew J; Graham Garry G; Day Richard O
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.
Clinical pharmacokinetics 2008;47(2):111-8.
2007: Day Richard O; Graham Garry G; Hicks Mark; McLachlan Andrew J; Stocker Sophie L; Williams Kenneth M
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.
Clinical pharmacokinetics 2007;46(8):623-44.
2007: Lu Christine Y; Williams Kenneth M; Day Richard O
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.
Australia and New Zealand health policy 2007;4():2.
2006: Coiera Enrico; Magrabi Farah; Westbrook Johanna I; Kidd Michael R; Day Richard O
Protocol for the Quick Clinical study: a randomised controlled trial to assess the impact of an online evidence retrieval system on decision-making in general practice.
BMC medical informatics and decision making 2006;6():33.
2005: Lassere Marissa N D; Johnson Kent R; Boers Maarten; Carlton Kerri; Day Richard O; de Wit Marten; Edwards I Ralph; Fries James F; Furst Daniel E; Kirwan John R; Tugwell Peter S; Woodworth Thasia G; Brooks Peter M
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
The Journal of rheumatology 2005;32(10):2037-41.
2005: Lassere Marissa N D; Johnson Kent R; Woodworth Thasia G; Furst Daniel E; Fries James F; Kirwan John R; Tugwell Peter S; Day Richard O; Brooks Peter M
Challenges and progress in adverse event ascertainment and reporting in clinical trials.
The Journal of rheumatology 2005;32(10):2030-2.
2005: Day Richard O; Graham Garry G
Paracetamol should be first-line therapy in osteoarthritis.
The Medical journal of Australia 2005;182(4):198-9; author reply 199.
2005: Lu Christine Y; Ritchie Jan; Williams Kenneth M; Day Richard O
Recent developments in targeting access to high cost medicines in Australia.
Australia and New Zealand health policy 2005;2():28.
2005: Graham Garry G; Scott Kieran F; Day Richard O
Tolerability of paracetamol.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(3):227-40.
2003: Graham Garry G; Scott Kieran F; Day Richard O
[Tolerability of paracetamol]
Drugs 2003;63 Spec No 2():43-6.
2002: Graham Garry G; Graham Robert I; Day Richard O
Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).
Current pharmaceutical design 2002;8(12):1063-75.
2001: Day R O
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspective.
Clinical and experimental rheumatology 2001;19(6 Suppl 25):S59-62.
2000: Day R O; Graham G G; Whelton A
The position of paracetamol in the world of analgesics.
American journal of therapeutics 2000;7(2):51-4.
1999: Browne G S; Nelson C; Nguyen T; Ellis B A; Day R O; Williams K M
Stereoselective and substrate-dependent inhibition of hepatic mitochondria beta-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and ketorolac.
Biochemical pharmacology 1999;57(7):837-44.
1999: Day R O; McLachlan A J; Graham G G; Williams K M
Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.
Clinical pharmacokinetics 1999;36(3):191-210.
1999: Graham G G; Day R O; Milligan M K; Ziegler J B; Kettle A J
Current concepts of the actions of paracetamol (acetaminophen) and NSAIDs.
Inflammopharmacology 1999;7(3):255-63.
1997: Shackel N A; Day R O; Kellett B; Brooks P M
Copper-salicylate gel for pain relief in osteoarthritis: a randomised controlled trial.
The Medical journal of Australia 1997;167(3):134-6.
1997: Conaghan P G; Crotty M; Oh E; Day R O; Brooks P M
Anti-rheumatic drug-prescribing behaviour of Australasian rheumatologists 1984-1994.
British journal of rheumatology 1997;36(4):487-90.
1995: Day R O; Francis H; Vial J; Geisslinger G; Williams K M
Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.
The Journal of rheumatology 1995;22(12):2295-303.
1995: Quinn D I; Day R O
Drug interactions of clinical importance. An updated guide.
Drug safety : an international journal of medical toxicology and drug experience 1995;12(6):393-452.
1995: Day R O; Quinn D I; Conaghan P G; Tett S E
Adverse drug reactions and their measurement in the rheumatic diseases.
The Journal of rheumatology 1995;22(5):983-8.
1995: Day R O; Geisslinger G; Paull P; Williams K M
The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers.
International journal of clinical pharmacology and therapeutics 1995;33(5):308-10.
1994: Conaghan P G; Day R O
Risks and benefits of drugs used in the management and prevention of gout.
Drug safety : an international journal of medical toxicology and drug experience 1994;11(4):252-8.
1994: Walker J S; Nguyen T V; Day R O
Clinical response to non-steroidal anti-inflammatory drugs in urate-crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability.
British journal of clinical pharmacology 1994;38(4):341-7.
1994: McLachlan A J; Tett S E; Cutler D J; Day R O
Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis.
British journal of rheumatology 1994;33(3):235-9.
1994: Day R O; Geisslinger G; Paull P; Williams K M
Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
British journal of clinical pharmacology 1994;37(1):79-81.
1994: McLachlan A J; Tett S E; Cutler D J; Day R O
Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate.
Chirality 1994;6(4):360-4.
1994: Tett S E; McLachlan A J; Cutler D J; Day R O
Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate.
Chirality 1994;6(4):355-9.
1993: Day R O; Wacher T; Cairns D; Conners G; McGrath M
Nailfold capillary circulation in osteoarthritis.
British journal of rheumatology 1993;32(12):1062-5.
1993: Walker J S; Arroyo J F; Nguyen T; Day R O
Analgesic efficacy of non-steroidal anti-inflammatory drugs in experimental pain in humans.
British journal of clinical pharmacology 1993;36(5):417-25.
1993: McLachlan A J; Tett S E; Cutler D J; Day R O
Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques.
British journal of clinical pharmacology 1993;36(5):405-11.
1993: Tett S E; Day R O; Cutler D J
Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.
The Journal of rheumatology 1993;20(11):1874-9.
1993: Walker J S; Knihinicki R D; Seideman P; Day R O
Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers.
Journal of pharmaceutical sciences 1993;82(8):787-90.
1993: McLachlan A J; Tett S E; Cutler D J; Day R O
Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.
British journal of clinical pharmacology 1993;36(1):78-81.
1993: Hicks M; Wong L S; Day R O
Suitability of reverse-phase columns from different sources for separation of uric acid from its oxidation products.
Analytical biochemistry 1993;210(2):428-30.
1993: Johnson A G; Seideman P; Day R O
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.
Drug safety : an international journal of medical toxicology and drug experience 1993;8(2):99-127.
1993: Hicks M; Wong L S; Day R O
Identification of products from oxidation of uric acid induced by hydroxyl radicals.
Free radical research communications 1993;18(6):337-51.
1993: Day R O
Variability in response to NSAIDs: what progress?
Agents and actions. Supplements 1993;44():3-6.
1992: Sandhu G S; Day R O
Factors affecting prescribing in general practice--a role play.
The Medical journal of Australia 1992;157(9):621-2.
1992: Tett S E; Cutler D J; Day R O
Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques.
Journal of pharmaceutical sciences 1992;81(2):155-9.
1992: Hicks M; Wong L S; Day R O
Antioxidant activity of propylthiouracil.
Biochemical pharmacology 1992;43(3):439-44.
1992: Zhao B; Geisslinger G; Hall I; Day R O; Williams K M
The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the rat.
Chirality 1992;4(3):137-41.
1991: Williams K M; Knihinicki R D; Day R O
Pharmacokinetics of the enantiomers of ibuprofen in the rabbit.
Agents and actions 1991;34(3-4):381-6.
1991: Knihinicki R D; Day R O; Williams K M
Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--II. Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters.
Biochemical pharmacology 1991;42(10):1905-11.
1991: Day R O; Williams K M; Graham S; Handel M
The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
Arthritis and rheumatism 1991;34(6):751-60.
1991: Joyce D A; Day R O; Murphy B R
The pharmacokinetics of albumin conjugates of D-penicillamine in humans.
Drug metabolism and disposition: the biological fate of chemicals 1991;19(2):309-11.
1990: Joyce D A; Day R O
D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
British journal of clinical pharmacology 1990;30(4):511-7.
1990: Johnson A G; Day R O; Seldon W A
A functional psychosis precipitated by quinidine.
The Medical journal of Australia 1990;153(1):47-9.
1990: Knihinicki R D; Day R O; Graham G G; Williams K M
Stereoselective disposition of ibuprofen and flurbiprofen in rats.
Chirality 1990;2(3):134-40.
1989: Day R O; Graham G G; Bieri D; Brown M; Cairns D; Harris G; Hounsell J; Platt-Hepworth S; Reeve R; Sambrook P N
Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers.
British journal of clinical pharmacology 1989;28(6):695-702.
1989: Knihinicki R D; Williams K M; Day R O
Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen.
Biochemical pharmacology 1989;38(24):4389-95.
1989: Sambrook P N; Champion G D; Browne C D; Cairns D; Cohen M L; Day R O; Graham S; Handel M; Jaworski R; Kempler S
Corticosteroid injection for osteoarthritis of the knee: peripatellar compared to intra-articular route.
Clinical and experimental rheumatology 1989;7(6):609-13.
1989: Tett S E; Cutler D J; Day R O; Brown K F
Bioavailability of hydroxychloroquine tablets in healthy volunteers.
British journal of clinical pharmacology 1989;27(6):771-9.
1988: Day R O; Paull P D; Lam S; Swanson B R; Williams K M; Wade D N
The effect of concurrent aspirin upon plasma concentrations of tenoxicam.
British journal of clinical pharmacology 1988;26(4):455-62.
1988: Day R O; Miners J; Birkett D J; Graham G G; Whitehead A
Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.
British journal of clinical pharmacology 1988;26(4):429-34.
1988: Day R O; Miners J O; Birkett D J; Whitehead A; Naidoo D; Hayes J; Savdie E
Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.
British journal of clinical pharmacology 1988;26(4):423-8.
1988: Day R O; Harris G; Brown M; Graham G G; Champion G D
Interaction of salicylate and corticosteroids in man.
British journal of clinical pharmacology 1988;26(3):334-7.
1988: Tett S E; Cutler D J; Day R O; Brown K F
A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.
British journal of clinical pharmacology 1988;26(3):303-13.
1988: Day R O; Williams K M; Graham G G; Lee E J; Knihinicki R D; Champion G D
Stereoselective disposition of ibuprofen enantiomers in synovial fluid.
Clinical pharmacology and therapeutics 1988;43(5):480-7.
1988: Patapanian H; Graham S; Sambrook P N; Browne C D; Champion G D; Cohen M L; Day R O
The oncogenicity of chlorambucil in rheumatoid arthritis.
British journal of rheumatology 1988;27(1):44-7.
1988: Day R O
Mode of action of non-steroidal anti-inflammatory drugs.
The Medical journal of Australia 1988;148(4):195-9.
1988: Champion G D; Cairns D R; Bieri D; Adena M A; Browne C D; Cohen M L; Day R O; Edmonds J P; Graham G G; de Jager J
Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
The Journal of rheumatology 1988;15(1):28-34.
1988: Williams K M; Day R O
The contribution of enantiomers to variability in response to anti-inflammatory drugs.
Agents and actions. Supplements 1988;24():76-84.
1988: Day R O; Breit S N; Cairns D; Champion G D
Aspects of the clinical trials of slow-acting anti-rheumatic drugs.
Agents and actions. Supplements 1988;24():121-33.
1987: Day R O; Lam S; Paull P; Wade D
Effect of food and various antacids on the absorption of tenoxicam.
British journal of clinical pharmacology 1987;24(3):323-8.
1987: Day R O; Graham G G; Williams K M; Champion G D; de Jager J
Clinical pharmacology of non-steroidal anti-inflammatory drugs.
Pharmacology & therapeutics 1987;33(2-3):383-433.
1986: Sambrook P N; Champion G D; Browne C D; Cohen M L; Compton P; Day R O; de Jager J
Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: a life-table analysis.
British journal of rheumatology 1986;25(4):372-5.
1984: McGirr E E; Browne C D; Champion G D; Day R O; Sambrook P N
Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
The Medical journal of Australia 1984;141(6):349-51.
1982: Sambrook P N; Browne C D; Champion G D; Day R O; Vallance J B; Warwick N
Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis.
The Journal of rheumatology 1982;9(6):932-4.
1982: Champion G D; Bieri D; Browne C D; Day R O; Graham G G; Haavisto T M; Sambrook P N; Vallance J B
Auranofin in rheumatoid arthritis.
The Journal of rheumatology. Supplement 1982;8():137-45.

Sign-in to see more